Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.26% | 24.42% | 40.83% | 42.10% | 44.10% |
| Total Depreciation and Amortization | -26.26% | 9.50% | 69.92% | 46.31% | 27.04% |
| Total Amortization of Deferred Charges | 463.64% | -128.45% | -131.67% | -131.66% | -- |
| Total Other Non-Cash Items | 1,432.17% | -66.45% | -89.51% | -95.85% | -101.42% |
| Change in Net Operating Assets | 73.93% | -39.82% | -1,104.03% | -1,104.03% | -1,104.03% |
| Cash from Operations | 22.45% | 6.39% | -13.02% | -13.61% | -12.27% |
| Capital Expenditure | -38.87% | 31.24% | 70.40% | 49.95% | 22.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 42.20% | 50.14% | 58.01% | 70.67% | 74.44% |
| Cash from Investing | -10.31% | 36.55% | 67.63% | 59.47% | 54.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -18.34% | 5.59% | 23.32% | 22.04% | 20.67% |
| Issuance of Common Stock | -16.97% | -8.73% | -0.54% | -0.54% | -0.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -22.83% | -11.67% | -0.99% | -1.17% | -1.22% |
| Foreign Exchange rate Adjustments | -6,021.43% | -50.73% | 69.23% | -21.94% | -98.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.37% | -39.70% | -362.77% | -413.09% | -121.45% |